Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Otodolor (Dr. Peithner)
- Development stage
- Unknown
- Lead developer
- Schwabe
- Administration
- Otic
01
Overview
Otodolor is an Austrian **homeopathic combination ear-drop medicine** for topical otic use. It contains homeopathic dilutions of *Capsicum annuum*, *Matricaria recutita*, *Pulsatilla pratensis*, silicic acid, and boric acid. It is indicated for symptomatic decongestion and pain relief in disorders of the external auditory canal, including irritation, redness, and eczematous crusting. Its labeled use is based exclusively on homeopathic experience rather than an established target-specific pharmacologic mechanism. Otodolor was originally developed by Dr. Peithner and was evaluated with Otodolor forte in a completed prospective non-interventional study in otitis externa.
- Brand names
- Otodolor
Beyond the preview
Go deeper on Otodolor (Dr. Peithner).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Otodolor (Dr. Peithner).